Search

Your search keyword '"Byrne, Julie"' showing total 216 results

Search Constraints

Start Over You searched for: Author "Byrne, Julie" Remove constraint Author: "Byrne, Julie"
216 results on '"Byrne, Julie"'

Search Results

3. 14. “Vibrant, open and accessible”: Students’ visions of higher education futures

10. Diagnosing history: Medicine in television period drama

14. Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study

15. Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study

17. Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM)

20. Shifting Mindsets; A Critical Commentary on Child Protection and Welfare, Disability, and Online Risk Through Critical Literature Review.

22. Heigh Ho, Heigh Ho: flexible labor contracts with real option characteristics

23. Real options? Labor contracts in an uncertain world

27. The Role of Social Work Education in Relation to Empathy and Self-Reported Resilience: Results from Entry to Exit of Social Work Education on the Island of Ireland during the COVID-19 Pandemic

31. Poster: MM-470 Exploring Alternative Dosing Regimens of Single-Agent Belantamab Mafodotin on Safety and Efficacy in Patients With Relapsed or Refractory Multiple Myeloma (RRMM): DREAMM-14

32. Sensory Desensitization Training for Successful Net Application and EEG/ERP Acquisition in Difficult to Test Children

33. OAB-049: Impact of baseline ocular conditions (BOCs) on belantamab mafodotin (belamaf)–related corneal events in patients (pts) with relapsed or refractory multiple myeloma (RRMM)

35. Exploring alternative dosing regimens of single-agent belantamab mafodotin on safety and efficacy in patients with relapsed or refractory multiple myeloma: DREAMM-14.

38. Handbook on Energy and Climate Change

39. Exploring Alternative Dosing Regimens of Single-Agent Belantamab Mafodotin on Safety and Efficacy in Patients with Relapsed or Refractory Multiple Myeloma: DREAMM-14

42. Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials

44. Ocular Health of Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Baseline Data from the DREAMM-2 Trial of Belantamab Mafodotin (Belamaf)

45. Social work students on the island of Ireland: a cross-sectional survey

46. Social work students on the island of Ireland: a cross-sectional survey.

Catalog

Books, media, physical & digital resources